Crinetics Pharmaceuticals · 2 days ago
Senior Specialist, GMP Quality Assurance
Wonder how qualified you are to the job?
Insider Connection @Crinetics Pharmaceuticals
Responsibilities
Perform batch record review and disposition activities for Clinical and Commercial Supplies.
Review and approve analytical and microbiological testing data for Drug Substance and Drug Product.
Coordinate Quality Events with CMOs and escalate to QA management.
Oversee QA aspects of API, Drug Product, Packaging, and Labeling Operations.
Represent QA in internal and external team meetings.
Support QA team on internal and external GMP audits.
Write and review Standard Operating Procedures.
Compile metrics of Batch Disposition, deviations, CAPAs, etc.
Other duties as assigned.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree in Chemistry, Engineering or any other scientific discipline and 5 years of relevant experience in a GMP environment that constitutes Drug Substance, Drug Product, and Packaging and Labeling.
Demonstrate knowledge of FDA/EMA/ICH standards and regulations.
Demonstrate ability to effectively organize, and work in a fast-paced environment.
Demonstrate ability to function individually and in a team environment.
Equipment: Working knowledge of relevant manufacturing and analytical testing equipment and instrument.
Software Knowledge: MS Office, e-QMS (e.g. Veeva), ERP systems.
Preferred
Solid dosage experience is preferred, however, experience in other dosage forms with relevant experience is acceptable.
Prior experience with Electronic QMS systems (Veeva preferred).
Benefits
Discretionary annual target bonus
Stock options
ESPP
401k match
Health insurance plans (medical, dental, vision, basic life insurance)
20 days of PTO
10 paid holidays
Winter company shutdown
Company
Crinetics Pharmaceuticals
Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.15BKey Investors
Frazier Healthcare PartnersNational Institutes of HealthPerceptive Advisors
2024-02-28Post Ipo Equity· $350M
2023-09-13Post Ipo Equity· $350M
2022-04-12Post Ipo Equity· $125M
Recent News
San Diego Business Journal
2024-04-25
Company data provided by crunchbase